Cell and gene therapies share fundamental objectives with conventional biologics. Their common challenges offer a natural starting point to solving downstream bottlenecks.
- New ISPE Framework Targets Uncertainty In Pharma's AI Deployment
- Disciplined CGT Will Win On 2026 Regulatory Flexibility
- In Vivo's Biggest Threat — Comparison To Old Models
- The 5-Layer Fix For AI Failure In Pharmaceutical Manufacturing
- Why Use Total Organic Carbon Analysis For Cleaning Validation?
- December 2025 — CDMO Opportunities And Threats Report
- The Great Cell Therapy Reset: Solving The Industrial Math Of Living Drugs
- Single-Use Standards Are Maturing, But The Process Remains King
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1213797500 doctor cancer patient, oncology]( "Gastric Cancer - Global Clinical Trial Landscape (2024)")
Gastric Cancer - Global Clinical Trial Landscape (2024)Discover the latest in gastric cancer research with this detailed report, highlighting new therapies, clinical trials, and future innovations.
-
![GettyImages-499481438 isolator]( "Turnkey Dismantling, Modification, And Relocation Of A Multi-Glove Isolator System")
Turnkey Dismantling, Modification, And Relocation Of A Multi-Glove Isolator SystemStrategic equipment relocation and retrofitting can reduce capital costs by fifty percent and save months in lead time. Learn how to modernize legacy systems while maintaining full GMP compliance.
-
![India Flag]( "Spotlight On India: Regulatory Enhancements, Modernization, And Robust Data Collection")
Spotlight On India: Regulatory Enhancements, Modernization, And Robust Data CollectionExplore India's adoption of global best practices, 24/7 work cycles, and audit readiness to ensure high standards of Good Clinical Practice, attract more trials, and provide robust data to stakeholders.
-
![GettyImages-1938555104-laboratory-equipment-scientist-windows]( "Advancing Drug Development With Optimized LC-MS/MS Bioanalysis")
Advancing Drug Development With Optimized LC-MS/MS BioanalysisExplore the critical role of sample preparation optimization and the application of liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) in bioanalytical method development.
-
![GettyImages-1293772957-scientist-laboratory-computer-drug-development]( "Techniques For PEGylation Site Identification")
Techniques For PEGylation Site IdentificationExamine how our innovative methods enable the precise identification of PEGylation sites, unlocking deeper insights into the structure, stability, and function of biotherapeutics.
-
![GettyImages-1159433153-microscope-scientist-cell-culture]( "High-Throughput Screening Of Ion Channel Variants Using Automated Patch Clamp Recordings In Assay Ready Cells")
High-Throughput Screening Of Ion Channel Variants Using Automated Patch Clamp Recordings In Assay Ready CellsHigh-throughput screening of KCNQ2 ion channel variants provides insights into epilepsy and treatment responses. This validated method supports rapid characterization for precision medicine.
-
![GettyImages-1169640506 oncology]( "EHR-To-EDC Success In A Complex, Adaptive Platform Trial")
EHR-To-EDC Success In A Complex, Adaptive Platform TrialI-SPY 2, one of the longest-running adaptive platform trials in oncology, is revolutionizing breast cancer research through a dynamic, data-driven approach to evaluating novel therapies.
-
![Antibodies And Cancer Cell GettyImages-1410479280]( "Antibody-Drug Conjugates Clinical Trials 2024")
Antibody-Drug Conjugates Clinical Trials 2024Gain comprehensive insights into Antibody-Drug Conjugates (ADCs) with our 2024 clinical trial report, offering a deep dive into new drug developments and market trends shaping cancer treatment.
-
![Xcellerex™ Magnetic Mixer]( "Determining The Power Numbers For A Single-Use Mixing System")
Determining The Power Numbers For A Single-Use Mixing SystemIn designing a mixing process for scale-up, the power number is a critical parameter. Explore the determined power numbers for a single-use mixer at various mixing speeds and fill levels.
-
![GettyImages-1583149311 biomanufacturing, automation, robotics]( "Enhancing Preclinical Cell Therapy Development")
Enhancing Preclinical Cell Therapy DevelopmentAutomation in cell therapy development boosts reproducibility, reduces error, and enhances yield. Learn how it’s reshaping preclinical workflows and accelerating clinical trial readiness.
NEWSLETTER ARCHIVE
- 02.06.26 -- New Podcast Episodes: Putting Pressure On CDMOs, BoB@JPM, Building Safer CRISPR Medicines For CVD
- 02.06.26 -- Sales & Operations Planning For Small Teams: Aligning Clinical Supply
- 02.05.26 -- The 5-Layer Fix For AI Failure In Pharmaceutical Manufacturing
- 02.04.26 -- Balancing The Elements: Strategies For Resilient Clinical Research
- 02.04.26 -- In Vivo's Biggest Threat — Comparison To Old Models
- Disciplined CGT Will Win On 2026 Regulatory Flexibility
- ARM's Tim Hunt On Expanding Patient Access, Smarter Regulation, And A More Sustainable Market In 2026
- Global Shifts And Strategic Resilience Will Shape CGT In 2026
- Why Efficiency In Multi-Modal CGT Manufacturing Is About Execution, Not Just Cost
- CSL's HEMGENIX Shows Durable Benefit, A New Future For Gene Therapy in Hemophilia B
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections
